ACHE and Alzheimer disease: For instance, acetylcholinesterase (AChE) inhibitors increase cholinergic levels in the brain to treat Alzheimer’s disease (AD), by enhancing the cholinergic levels in the brain [9], while monoamine oxidase (MAO) inhibitors reduce oxidative damage and have the potential for treating AD [10].